首页> 美国卫生研究院文献>Drug Design Development and Therapy >Celastrol inhibits prostaglandin E2-induced proliferation and osteogenic differentiation of fibroblasts isolated from ankylosing spondylitis hip tissues in vitro
【2h】

Celastrol inhibits prostaglandin E2-induced proliferation and osteogenic differentiation of fibroblasts isolated from ankylosing spondylitis hip tissues in vitro

机译:Celastrol抑制前列腺素E2诱导的体外从强直性脊柱炎髋关节组织分离的成纤维细胞增殖和成骨分化

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundHeterotopic ossification on the enthesis, which develops after subsequent inflammation, is one of the most distinctive features in ankylosing spondylitis (AS). Prostaglandin E2 (PGE-2) serves as a key mediator of inflammation and bone remodeling in AS. Celastrol, a well-known Chinese medicinal herb isolated from Tripterygium wilfordii, is widely used in treating inflammatory diseases, including AS. It has been proven that it can inhibit lipopolysac-charide-induced expression of various inflammation mediators, such as PGE-2. However, the mechanism by which celastrol inhibits inflammation-induced bone forming in AS is unclear.
机译:背景继发性炎症后发展成的异位骨化是强直性脊柱炎(AS)的最独特特征之一。前列腺素E2(PGE-2)是AS中炎症和骨骼重塑的关键介质。 Celastrol是一种从雷公藤中分离的著名中草药,被广泛用于治疗包括AS在内的炎性疾病。业已证明,它可以抑制脂多糖诱导的各种炎症介质(如PGE-2)的表达。然而,尚不清楚Celastrol抑制AS中炎症诱导的骨形成的机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号